Skip to search formSkip to main contentSkip to account menu

Adenosine A3 Receptor Agonists

Drugs that selectively bind to and activate ADENOSINE A3 RECEPTORS.
National Institutes of Health

Related topics

Related topics

4 relations
In Bloodaspects of radiation effectschemical synthesisstandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
A binding kinetics study of human adenosine A3 receptor agonists
Review
2018
Review
2018
Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature.
BACKGROUND Adenosine is a purine, with an adenine group and a ribose sugar, formed endogenously by ATP catabolism both… 
2016
2016
Pharmacology of the Adenosine A3 Receptor in the Vasculature and Essential Hypertension
Background Essential hypertension is considered to be a multifactorial disorder and its aetiology has yet to be clearly… 
2006
2006
Dry eye disease treatment for adenosine a3 receptor agonists
2005
2005
Dry eye disease therapeutic adenosine a3 receptor agonists including Sjogren's Syndrome
Highly Cited
1997
Highly Cited
1997
Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo.
Adenosine and related analogs have been shown to regulate a variety of cell functions through different classes of adenosine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)